Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yueyuan Yao"'
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-10 (2024)
Abstract Background Platinum-etoposide chemotherapy combined with immune checkpoint inhibitors (ICIs) has been recommended as the first-line standard treatment for extensive-stage small-cell lung cancer (ES-SCLC). However, the effect of thoracic radi
Externí odkaz:
https://doaj.org/article/d7eb242346904cc3a33934f4af582653
Autor:
Butuo Li, Wenru Qin, Linlin Yang, Haoqian Li, Chao Jiang, Yueyuan Yao, Shuping Cheng, Bing Zou, Bingjie Fan, Taotao Dong, Linlin Wang
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Immunotherapy has significantly improved survival of esophageal squamous cell cancer (ESCC) patients, however the clinical benefit was limited to only a small portion of patients. This study aimed to perform a deep learning signat
Externí odkaz:
https://doaj.org/article/fee00fb69b364a43a7837a917b6b820c
Publikováno v:
Cancer Medicine, Vol 12, Iss 13, Pp 13873-13884 (2023)
Abstract Objectives Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK TKIs) have shown remarkable clinical activity in patients with non‐small‐cell lung cancer (NSCLC). However, pneumonitis is a serious side effect of ALK TKIs in NSCLC p
Externí odkaz:
https://doaj.org/article/5e312b8018e44dcfb9c10b3a49a6f32c
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Background Immune checkpoint inhibitors (ICIs) combined with chemotherapy have been recommended as the standard treatment for advanced NSCLC patients without driver‐gene mutations. However, there are different genetic characteristics and b
Externí odkaz:
https://doaj.org/article/c230b22d104046c990612f4e89f715c8
Autor:
Butuo Li, Linlin Yang, Chao Jiang, Yueyuan Yao, Haoqian Li, Shuping Cheng, Bing Zou, Bingjie Fan, Linlin Wang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe addition of bevacizumab was found to be associated with prolonged survival whether in combination with chemotherapy, tyrosine kinase inhibitors or immune checkpoint inhibitors in the treatment landscape of advanced non-small cell lung c
Externí odkaz:
https://doaj.org/article/1a92e4cb4b54489ab980c2f42adc5125
Publikováno v:
Cancer Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4fe4fc70a7a241f3ed763311fce3026
https://doi.org/10.1002/cam4.5913
https://doi.org/10.1002/cam4.5913
Autor:
Butuo Li, Linlin Yang, Huan Zhang, Haoqian Li, Chao Jiang, Yueyuan Yao, Shuping Cheng, Bing Zou, Bingjie Fan, Taotao Dong, Linlin Wang
Publikováno v:
Modern Pathology. 36:100208
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a3d4f99523b9ea08d89a9f95bc7ffe3
https://doi.org/10.1016/j.modpat.2023.100208
https://doi.org/10.1016/j.modpat.2023.100208
Publikováno v:
Journal of Clinical Oncology. 40:2580-2580
2580 Background: Early prediction of symptomatic pneumonitis (grade ≥ 2) could potentially assist the comprehensive management for non-small cell lung cancer (NSCLC) patients who received radiotherapy combined with immunotherapy. A more accurate in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::083d4182299b419d5e4a960a427363a1
https://doi.org/10.1200/jco.2022.40.16_suppl.2580
https://doi.org/10.1200/jco.2022.40.16_suppl.2580